LIFE Share Price Performance
NOK 0.74
-10.86 (-93.64%)
96.1% undervalued intrinsic discount
NOK 19.00
Fair Value
Price NOK 0.74
AnalystConsensusTarget NOK 19.00
Fair ValueNOK 19.00
Share Pricen/a
Lifecare ASA Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
LIFE Community Narratives
AN
Fair Value NOK 19 96.1% undervalued intrinsic discount
TTP Collaboration And Sensor Chemistry Will Streamline Manufacturing
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
TTP Collaboration And Sensor Chemistry Will Streamline Manufacturing
Key Takeaways Strategic partnerships and technological advancements could significantly enhance market position and revenue growth through improved product efficiency and expanded market access. Future European market entry and expected operational cost reductions aim to boost Lifecare's financial stability and allow growth-focused investment.Read more
17
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
NOK 19
96.1% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
162.85% p.a.
Profit Margin
17.78%
Future PE
50.74x
Price in 2028
NOK 20.52
Trending Discussion
Recently Updated Narratives
AN
TTP Collaboration And Sensor Chemistry Will Streamline Manufacturing
Fair Value: NOK 19 96.1% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Lifecare ASA Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 19, 2026
- -6.51
- 100.00%
- -6,794.25%
- 0%
About LIFE
- Founded
- 2006
- Employees
- 28
- CEO
- WebsiteView website
Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes and for veterinary applications. It also develops and manufactures a nanostrain biosensor, an ultra-small device that measures pressure, temperature, force, or various other performance indicators in live tissue; and medical devices that remove subdermal implants. Lifecare ASA was founded in 2006 and is headquartered in Bergen, Norway.
